Loading...
Naxitamab
Pida mas información
935106861
info@markelab.com
Precio
412.5€ (100 µg)
proveedor
Abbexareference
abx831506Tested Applications
ELISA, WBreactivity
Humanstatus
This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications (RUOclonality
MonoclonalDescripción
Naxitamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Ganglioside GD2, Naxitamab is a chimeric humanized monoclonal antibody targeting the GD2 antigen. GD2 antigen is expressed on the surface of tumors generated by neuroectoderm, including neuroblastoma, melanoma and osteosarcoma. By binding to the GD2 antigen on the tumor surface, naxitamab can trigger antibody-mediated cytotoxicity and activate the complement system in the immune system to achieve the effect of killing tumors.
Características del producto
category
Biosimilars
host
Human, Mouse
clonality
Monoclonal
reactivity
Human
immunogen target
Ganglioside GD2
host
Human, Mouse
isotype
IgG1 Kappa
conjugation
Unconjugated
form
Liquid
tested applications
ELISA, WB
size 1
100 µg
size 2
1 mg
expression
Recombinant
purity
> 95%
purification
Purified from cell culture supernatants by Protein A/G chromatography.
buffer
0.01 M PBS. pH 7.4.
storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
dry ice
No
availability
Shipped within 7-12 working days.
alias
Biosimilars
note
CAS Number 1879925-92-4
Quizá le pueda interesar
Goat MAP28 ELISA Kit
proveedor
FineTestreference
EG0012reactivity
goatstatus
RUOPrecio a consultar
Ver másHRP conjugated Streptavidin
proveedor
FineTestreference
FNSA-0001Tested Applications
ELISA, WBstatus
RUOPrecio a consultar
Ver másHRP conjugated Goat Anti-Mouse FC
proveedor
FineTestreference
FNSA-0002Tested Applications
ELISA, WBreactivity
mousestatus
RUOPrecio a consultar
Ver más